- QMRO Home
- Blizard Institute
- Centre for Neuroscience, Surgery and Trauma
- Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.
Browse
Administrators only